Follow
Jainu Ajit
Jainu Ajit
Harvard Medical School
Verified email at hms.harvard.edu
Title
Cited by
Cited by
Year
Synthesis and Evaluation of Arylamides with Hydrophobic Side Chains for Insulin Aggregation Inhibition
IS Yogesh M. Gangarde Anirban Das Jainu Ajit
ChemPlusChem 86 (5), 750-757, 2021
82021
Receptor–Ligand Kinetics Influence the Mechanism of Action of Covalently Linked TLR Ligands
FW Kimani, J Ajit, A Galluppi, S Manna, WJ Howitz, S Tang, ...
ACS chemical biology 16 (2), 380-388, 2021
82021
Palladium-catalyzed interceptive decarboxylative addition of allyl carbonates with carbonyl group
TV Baiju, N Joseph, J Ajit, P Prakash, KV Radhakrishnan, S Varughese, ...
Synlett 25 (09), 1246-1252, 2014
42014
Site-specific antigen-adjuvant conjugation using cell-free protein synthesis enhances antigen presentation and CD8+ T-cell response
APEK Adam M. Weiss, Jainu Ajit, Tyler J. Albin, Neeraj Kapoor, Shilpa Maroju ...
Scientific Reports, 6267, 2021
32021
Temporal Control of Trained Immunity via Encapsulated Release of β‐Glucan Improves Therapeutic Applications
J Ajit, B Cassaidy, S Tang, A Solanki, Q Chen, J Shen, AP Esser Kahn
Advanced Healthcare Materials 11 (18), 2200819, 2022
22022
β-glucan induced trained immunity enhances antibody levels in a vaccination model in mice
J Ajit, Q Chen, T Ung, MG Rosenberger, J Kim, A Solanki, J Shen, ...
bioRxiv, 2024.04. 11.588932, 2024
2024
Novel non-immunogenic trained immunity inducing small molecule with improved anti-tumor properties
J Ajit, HR Knight, Q Chen, A Solanki, J Shen, AP Esser-Kahn
bioRxiv, 2024.03. 22.585780, 2024
2024
Temporal Control of Trained Immunity via Encapsulated Release of 𝜷-Glucan Improves Therapeutic Applications
J Ajit, B Cassaidy, S Tang, A Solanki, Q Chen, J Shen, APE Kahn
2022
Determining the mechanism of activation of linked toll-like receptor agonists synergies
J Ajit, A Esser-Kahn
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY 258, 2019
2019
The system can't perform the operation now. Try again later.
Articles 1–9